Related Experiment Video
Updated: Aug 8, 2026

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein
Published on: December 3, 2010
Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms
1Department of Microbiology and Immunology, Queen's University, Kingston, ON, Canada. poolek@post.queensu.ca
Abstract:
Pseudomonas aeruginosa is an opportunistic human pathogen characterized by an innate resistance to multiple antimicrobial agents. A major contribution to this intrinsic multidrug resistance is provided by a number of broadly-specific multidrug efflux systems, including MexAB-OprM and MexXY-OprM. In addition, these and two additional tripartite efflux systems, MexCD-OprJ and MexEF-OprN, promote acquired multidrug resistance as a result of mutational hyperexpression of the efflux genes. In addition to antibiotics, these pumps promote export of numerous dyes, detergents, inhibitors, disinfectants, organic solvents and homoserine lactones involved in quorum sensing. The efflux pump proteins are highly homologous and consist of a cytoplasmic membrane-associated drug-proton antiporter of the Resistance-Nodulation-Division (RND) family, an outer membrane channel-forming protein [sometimes called outer membrane factor (OMF)] and a periplasmic membrane fusion protein (MFP). Homologues of these systems have been described in Stenotrophomonas maltophilia, Burkholderia cepacia, Burkholderia pseudomallei and the non-pathogen Pseudomonas putida, where they play a role in export of and resistance to multiple antimicrobial agents and/or organic solvents. Although the natural function of these multidrug efflux systems is largely unknown, their contribution to antibiotic resistance and their conservation in a number of important human pathogens makes them logical targets for therapeutic intervention.
Insights
Pseudomonas aeruginosa utilizes multidrug efflux systems (MexAB-OprM, MexXY-OprM, MexCD-OprJ, MexEF-OprN) for innate and acquired resistance to antimicrobials. These pumps export various compounds, making them key targets for therapeutic intervention.
Area of Science:
- Microbiology
- Molecular Biology
- Biochemistry
Background:
- Pseudomonas aeruginosa is an opportunistic pathogen with significant antimicrobial resistance.
- Multidrug efflux systems, such as MexAB-OprM and MexXY-OprM, contribute to this resistance.
- Additional systems (MexCD-OprJ, MexEF-OprN) also confer acquired resistance through gene hyperexpression.
Purpose of the Study:
- To investigate the role of multidrug efflux systems in Pseudomonas aeruginosa.
- To highlight the contribution of these systems to both intrinsic and acquired drug resistance.
- To identify these efflux systems as potential therapeutic targets.
Main Methods:
- Analysis of Pseudomonas aeruginosa's intrinsic and acquired multidrug resistance mechanisms.
- Identification and characterization of tripartite efflux systems (RND, OMF, MFP proteins).
- Comparative analysis of homologous systems in related bacterial species.
Main Results:
- Identified four major tripartite efflux systems (MexAB-OprM, MexXY-OprM, MexCD-OprJ, MexEF-OprN) in P. aeruginosa.
- Demonstrated their role in exporting antibiotics, dyes, detergents, and other compounds.
- Observed conservation of similar systems in other bacterial species like S. maltophilia and Burkholderia spp.
Conclusions:
- Multidrug efflux systems are critical for P. aeruginosa's resistance.
- These systems contribute to the export of a wide range of toxic substances.
- Targeting these conserved efflux pumps presents a promising strategy for combating P. aeruginosa infections.
More Related Videos
Related Concept Videos
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Gene Regulation in Microbial Communities: Quorum Sensing
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance

